{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T22:28:16Z","timestamp":1792448896127,"version":"4.5.0"},"reference-count":85,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1016\/j.ejphar.2021.174419","type":"journal-article","created":{"date-parts":[[2021,8,12]],"date-time":"2021-08-12T03:37:05Z","timestamp":1628739425000},"page":"174419","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":49,"special_numbering":"C","title":["Arctigenin, an anti-tumor agent; a cutting-edge topic and up-to-the-minute approach in cancer treatment"],"prefix":"10.1016","volume":"909","author":[{"given":"Arezoo Gowhari","family":"Shabgah","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wanich","family":"Suksatan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad Harun","family":"Achmad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dmitry O.","family":"Bokov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walid Kamal","family":"Abdelbasset","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3287-2781","authenticated-orcid":false,"given":"Fatemeh","family":"Ezzatifar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sasan","family":"Hemmati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hamed","family":"Mohammadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Davood","family":"Soleimani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farhad","family":"Jadidi-Niaragh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Majid","family":"Ahmadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jamshid Gholizadeh","family":"Navashenaq","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2021.174419_bib1","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1158\/0008-5472.CAN-05-3143","article-title":"Identification of arctigenin as an antitumor agent having the ability to eliminate the tolerance of cancer cells to nutrient starvation","volume":"66","author":"Awale","year":"2006","journal-title":"Canc. Res."},{"key":"10.1016\/j.ejphar.2021.174419_bib2","first-page":"505","article-title":"Arctigenin induces the apoptosis of primary effusion lymphoma cells under conditions of glucose deprivation","volume":"52","author":"Baba","year":"2018","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.ejphar.2021.174419_bib3","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1080\/14786419.2017.1314279","article-title":"Synthesis and antitumour activity of arctigenin amino acid ester derivatives against H22 hepatocellular carcinoma","volume":"32","author":"Cai","year":"2018","journal-title":"Nat. Prod. Res."},{"key":"10.1016\/j.ejphar.2021.174419_bib4","doi-asserted-by":"crossref","first-page":"3307","DOI":"10.1038\/s41598-018-21722-1","article-title":"Experimental study of the anti-tumour activity and pharmacokinetics of arctigenin and its valine ester derivative","volume":"8","author":"Cai","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejphar.2021.174419_bib5","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.1016\/j.biopha.2016.10.093","article-title":"Synthesis and pharmacological activity evaluation of arctigenin monoester derivatives","volume":"84","author":"Chen","year":"2016","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.ejphar.2021.174419_bib6","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S1567-5769(01)00153-9","article-title":"Potent inhibition of lipopolysaccharide-inducible nitric oxide synthase expression by dibenzylbutyrolactone lignans through inhibition of I-kappaBalpha phosphorylation and of p65 nuclear translocation in macrophages","volume":"2","author":"Cho","year":"2002","journal-title":"Int. Immunopharm."},{"key":"10.1016\/j.ejphar.2021.174419_bib7","doi-asserted-by":"crossref","first-page":"632959","DOI":"10.1155\/2012\/632959","article-title":"Polyphenols: key issues involved in chemoprevention of prostate cancer","volume":"2012","author":"Cimino","year":"2012","journal-title":"Oxid Med Cell Longev"},{"key":"10.1016\/j.ejphar.2021.174419_bib8","doi-asserted-by":"crossref","first-page":"329","DOI":"10.18632\/oncotarget.13393","article-title":"Arctigenin inhibits STAT3 and exhibits anticancer potential in human triple-negative breast cancer therapy","volume":"8","author":"Feng","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.ejphar.2021.174419_bib9","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1038\/aps.2018.32","article-title":"Overview of the anti-inflammatory effects, pharmacokinetic properties and clinical efficacies of arctigenin and arctiin from Arctium lappa L","volume":"39","author":"Gao","year":"2018","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.ejphar.2021.174419_bib10","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1208\/s12248-014-9664-x","article-title":"Elucidation of arctigenin pharmacokinetics after intravenous and oral administrations in rats: integration of in vitro and in vivo findings via semi-mechanistic pharmacokinetic modeling","volume":"16","author":"Gao","year":"2014","journal-title":"AAPS J."},{"key":"10.1016\/j.ejphar.2021.174419_bib11","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.immuni.2019.06.025","article-title":"Inflammation and cancer: triggers, mechanisms, and consequences","volume":"51","author":"Greten","year":"2019","journal-title":"Immunity"},{"key":"10.1016\/j.ejphar.2021.174419_bib12","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1097\/CAD.0b013e328362fb84","article-title":"Inhibition of angiogenesis: a novel antitumor mechanism of the herbal compound arctigenin","volume":"24","author":"Gu","year":"2013","journal-title":"Anti Canc. Drugs"},{"key":"10.1016\/j.ejphar.2021.174419_bib13","doi-asserted-by":"crossref","first-page":"104721","DOI":"10.1016\/j.phrs.2020.104721","article-title":"Arctigenin, a novel TMEM16A inhibitor for lung adenocarcinoma therapy","volume":"155","author":"Guo","year":"2020","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.ejphar.2021.174419_bib14","first-page":"4770","article-title":"Tumor development under angiogenic signaling: a dynamical theory of tumor growth, treatment response, and postvascular dormancy","volume":"59","author":"Hahnfeldt","year":"1999","journal-title":"Canc. Res."},{"key":"10.1016\/j.ejphar.2021.174419_bib15","doi-asserted-by":"crossref","DOI":"10.3390\/molecules21091135","article-title":"Arctigenin inhibits lung metastasis of colorectal cancer by regulating cell viability and metastatic phenotypes","volume":"21","author":"Han","year":"2016","journal-title":"Molecules"},{"key":"10.1016\/j.ejphar.2021.174419_bib16","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0092-8674(00)81683-9","article-title":"The hallmarks of cancer","volume":"100","author":"Hanahan","year":"2000","journal-title":"Cell"},{"key":"10.1016\/j.ejphar.2021.174419_bib17","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1038\/s41598-020-58354-3","article-title":"Arctigenin inhibits prostate tumor growth in high-fat diet fed mice through dual actions on adipose tissue and tumor","volume":"10","author":"Hao","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejphar.2021.174419_bib18","doi-asserted-by":"crossref","first-page":"235","DOI":"10.3389\/fvets.2019.00235","article-title":"Pharmacokinetics of arctigenin and fructus Arctii powder in piglets","volume":"6","author":"He","year":"2019","journal-title":"Frontiers in Veterinary Science"},{"key":"10.1016\/j.ejphar.2021.174419_bib19","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1080\/14786419.2012.666745","article-title":"Pharmacokinetic study of arctigenin in rat plasma and organ tissue by RP-HPLC method","volume":"27","author":"He","year":"2013","journal-title":"Nat. Prod. Res."},{"key":"10.1016\/j.ejphar.2021.174419_bib20","doi-asserted-by":"crossref","first-page":"3178","DOI":"10.1021\/jf010038a","article-title":"In vitro metabolism of plant lignans: new precursors of mammalian lignans enterolactone and enterodiol","volume":"49","author":"Heinonen","year":"2001","journal-title":"J. Agric. Food Chem."},{"key":"10.1016\/j.ejphar.2021.174419_bib21","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1038\/82732","article-title":"Fas triggers an alternative, caspase-8-independent cell death pathway using the kinase RIP as effector molecule","volume":"1","author":"Holler","year":"2000","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.ejphar.2021.174419_bib22","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.freeradbiomed.2013.10.004","article-title":"Arctigenin, a dietary phytoestrogen, induces apoptosis of estrogen receptor-negative breast cancer cells through the ROS\/p38 MAPK pathway and epigenetic regulation","volume":"67","author":"Hsieh","year":"2014","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.ejphar.2021.174419_bib23","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1111\/bcpt.12270","article-title":"Arctigenin promotes apoptosis in ovarian cancer cells via the iNOS\/NO\/STAT3\/survivin signalling","volume":"115","author":"Huang","year":"2014","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"key":"10.1016\/j.ejphar.2021.174419_bib24","doi-asserted-by":"crossref","first-page":"598","DOI":"10.3892\/or.2017.5667","article-title":"Arctigenin inhibits triple-negative breast cancers by targeting CIP2A to reactivate protein phosphatase 2A","volume":"38","author":"Huang","year":"2017","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.ejphar.2021.174419_bib25","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1111\/cas.13086","article-title":"Phase I trial of GBS-01 for advanced pancreatic cancer refractory to gemcitabine","volume":"107","author":"Ikeda","year":"2016","journal-title":"Canc. Sci."},{"key":"10.1016\/j.ejphar.2021.174419_bib26","first-page":"6201","article-title":"Remarkable tolerance of tumor cells to nutrient deprivation: possible new biochemical target for cancer therapy","volume":"60","author":"Izuishi","year":"2000","journal-title":"Canc. Res."},{"key":"10.1016\/j.ejphar.2021.174419_bib27","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1016\/j.intimp.2011.05.016","article-title":"Arctigenin induces cell cycle arrest by blocking the phosphorylation of Rb via the modulation of cell cycle regulatory proteins in human gastric cancer cells","volume":"11","author":"Jeong","year":"2011","journal-title":"Int. Immunopharm."},{"key":"10.1016\/j.ejphar.2021.174419_bib28","doi-asserted-by":"crossref","first-page":"3542613","DOI":"10.1155\/2020\/3542613","article-title":"Arctigenin inhibits glioblastoma proliferation through the AKT\/mTOR pathway and induces autophagy","volume":"2020","author":"Jiang","year":"2020","journal-title":"BioMed Res. Int."},{"key":"10.1016\/j.ejphar.2021.174419_bib29","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1038\/nrc1317","article-title":"Microtubules as a target for anticancer drugs","volume":"4","author":"Jordan","year":"2004","journal-title":"Nat. Rev. Canc."},{"key":"10.1016\/j.ejphar.2021.174419_bib30","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1101\/gad.7.3.331","article-title":"Direct binding of cyclin D to the retinoblastoma gene product (pRb) and pRb phosphorylation by the cyclin D-dependent kinase CDK4","volume":"7","author":"Kato","year":"1993","journal-title":"Genes Dev."},{"key":"10.1016\/j.ejphar.2021.174419_bib31","doi-asserted-by":"crossref","first-page":"7414","DOI":"10.1038\/sj.onc.1206945","article-title":"Alterations in the apoptotic machinery and their potential role in anticancer drug resistance","volume":"22","author":"Kaufmann","year":"2003","journal-title":"Oncogene"},{"key":"10.1016\/j.ejphar.2021.174419_bib32","first-page":"3642","article-title":"The antitumor function of arctigenin in human retinoblastoma cells is mediated by jagged-1","volume":"19","author":"Ke","year":"2019","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.ejphar.2021.174419_bib33","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1002\/jcp.22085","article-title":"Arctigenin blocks the unfolded protein response and shows therapeutic antitumor activity","volume":"224","author":"Kim","year":"2010","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.ejphar.2021.174419_bib34","doi-asserted-by":"crossref","DOI":"10.1177\/1934578X1601101011","article-title":"Enzyme-hydrolyzed fruit of Jurinea mollis: a rich source of (-)-(8R,8\u2032R)-Arctigenin","volume":"11","author":"K\u00f6nye","year":"2016","journal-title":"Natural Product Communications"},{"key":"10.1016\/j.ejphar.2021.174419_bib35","doi-asserted-by":"crossref","first-page":"823","DOI":"10.2174\/138955711796575489","article-title":"Plant phenylpropanoids as emerging anti-inflammatory agents","volume":"11","author":"Korkina","year":"2011","journal-title":"Mini Rev. Med. Chem."},{"key":"10.1016\/j.ejphar.2021.174419_bib36","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.ejmech.2012.11.031","article-title":"Synthesis and antitumor evaluation of arctigenin derivatives based on antiausterity strategy","volume":"60","author":"Kudou","year":"2013","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejphar.2021.174419_bib37","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.foodres.2011.12.023","article-title":"Plant and mammalian lignans: a review of source, intake, metabolism, intestinal bacteria and health","volume":"46","author":"Landete","year":"2012","journal-title":"Food Res. Int."},{"key":"10.1016\/j.ejphar.2021.174419_bib38","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1089\/ten.2006.12.2093","article-title":"Angiogenesis in tissue engineering: breathing life into constructed tissue substitutes","volume":"12","author":"Laschke","year":"2006","journal-title":"Tissue Eng."},{"key":"10.1016\/j.ejphar.2021.174419_bib39","doi-asserted-by":"crossref","first-page":"2513","DOI":"10.1021\/acs.jafc.7b00112","article-title":"\u03b2-Catenin mediates anti-adipogenic and anticancer effects of arctigenin in preadipocytes and breast cancer cells","volume":"65","author":"Lee","year":"2017","journal-title":"J. Agric. Food Chem."},{"key":"10.1016\/j.ejphar.2021.174419_bib40","first-page":"1374","article-title":"Anti-metastatic effects of arctigenin are regulated by MAPK\/AP-1 signaling in 4T-1 mouse breast cancer cells","volume":"21","author":"Lee","year":"2020","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.ejphar.2021.174419_bib41","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s11010-020-03699-6","article-title":"Arctigenin induces necroptosis through mitochondrial dysfunction with CCN1 upregulation in prostate cancer cells under lactic acidosis","volume":"467","author":"Lee","year":"2020","journal-title":"Mol. Cell. Biochem."},{"key":"10.1016\/j.ejphar.2021.174419_bib42","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1016\/j.bbrc.2018.10.045","article-title":"Arctigenin shows preferential cytotoxicity to acidity-tolerant prostate carcinoma PC-3\u00a0cells through ROS-mediated mitochondrial damage and the inhibition of PI3K\/Akt\/mTOR pathway","volume":"505","author":"Lee","year":"2018","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ejphar.2021.174419_bib43","first-page":"87","article-title":"Arctigenin induces apoptosis in colon cancer cells through ROS\/p38MAPK pathway","volume":"21","author":"Li","year":"2016","journal-title":"J buon"},{"key":"10.1016\/j.ejphar.2021.174419_bib44","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1111\/bph.14816","article-title":"Natural compounds as potential adjuvants to cancer therapy: preclinical evidence","volume":"177","author":"Lin","year":"2020","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2021.174419_bib45","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1056\/NEJMra1310050","volume":"370","author":"Linkermann","year":"2014","journal-title":"Necroptosis. N Engl J Med"},{"key":"10.1016\/j.ejphar.2021.174419_bib46","doi-asserted-by":"crossref","first-page":"179","DOI":"10.3892\/or.2016.5269","article-title":"Arctigenin, a lignan from Arctium lappa L., inhibits metastasis of human breast cancer cells through the downregulation of MMP-2\/-9 and heparanase in MDA-MB-231 cells","volume":"37","author":"Lou","year":"2017","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.ejphar.2021.174419_bib47","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1111\/jphp.13180","article-title":"Activation of reactive oxygen species-mediated mitogen-activated protein kinases pathway regulates both extrinsic and intrinsic apoptosis induced by arctigenin in Hep G2","volume":"72","author":"Lu","year":"2020","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.ejphar.2021.174419_bib48","doi-asserted-by":"crossref","first-page":"355","DOI":"10.2174\/156720110793566272","article-title":"Targeting the resistance of pancreatic cancer cells to nutrient deprivation: anti-austerity compounds","volume":"7","author":"Magolan","year":"2010","journal-title":"Curr. Drug Deliv."},{"key":"10.1016\/j.ejphar.2021.174419_bib49","doi-asserted-by":"crossref","first-page":"727","DOI":"10.3892\/ijo.2016.3825","article-title":"The anti-metastatic effects of the phytoestrogen arctigenin on human breast cancer cell lines regardless of the status of ER expression","volume":"50","author":"Maxwell","year":"2017","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.ejphar.2021.174419_bib50","first-page":"1339","article-title":"Arctigenin inhibits the activation of the mTOR pathway, resulting in autophagic cell death and decreased ER expression in ER-positive human breast cancer cells","volume":"52","author":"Maxwell","year":"2018","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.ejphar.2021.174419_bib51","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.fitote.2014.10.017","article-title":"Endogenous enzyme-hydrolyzed fruit of Cirsium brachycephalum: optimal source of the antiproliferative lignan trachelogenin regulating the Wnt\/\u03b2-Catenin signaling pathway in the SW480 colon adenocarcinoma cell line","volume":"100","author":"Mervai","year":"2015","journal-title":"Fitoterapia"},{"key":"10.1016\/j.ejphar.2021.174419_bib52","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1007\/s00383-019-04473-6","article-title":"Arctigenin induces apoptosis in human hepatoblastoma cells","volume":"35","author":"Naoe","year":"2019","journal-title":"Pediatr. Surg. Int."},{"key":"10.1016\/j.ejphar.2021.174419_bib53","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1021\/acs.jnatprod.5b01055","article-title":"Natural products as sources of new drugs from 1981 to 2014","volume":"79","author":"Newman","year":"2016","journal-title":"J. Nat. Prod."},{"key":"10.1016\/j.ejphar.2021.174419_bib54","doi-asserted-by":"crossref","first-page":"14721","DOI":"10.1002\/jcp.28230","article-title":"Targeted-nanoliposomal combretastatin A4 (CA-4) as an efficient antivascular candidate in the metastatic cancer treatment","volume":"234","author":"Nik","year":"2019","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.ejphar.2021.174419_bib55","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1007\/s11418-020-01396-8","article-title":"Arctigenin suppresses cell proliferation via autophagy inhibition in hepatocellular carcinoma cells","volume":"74","author":"Okubo","year":"2020","journal-title":"J. Nat. Med."},{"key":"10.1016\/j.ejphar.2021.174419_bib56","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1038\/35021093","article-title":"Molecular portraits of human breast tumours","volume":"406","author":"Perou","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.ejphar.2021.174419_bib57","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.canlet.2020.08.033","article-title":"Arctigenin disrupts NLRP3 inflammasome assembly in colonic macrophages via downregulating fatty acid oxidation to prevent colitis-associated cancer","volume":"491","author":"Qiao","year":"2020","journal-title":"Canc. Lett."},{"key":"10.1016\/j.ejphar.2021.174419_bib58","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1038\/ncb3578","article-title":"Obesity alters the lung myeloid cell landscape to enhance breast cancer metastasis through IL5 and GM-CSF","volume":"19","author":"Quail","year":"2017","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.ejphar.2021.174419_bib59","doi-asserted-by":"crossref","first-page":"5826","DOI":"10.1158\/0008-5472.CAN-19-1058","article-title":"Tumor-derived thymic stromal lymphopoietin expands bone marrow B-cell precursors in circulation to support metastasis","volume":"79","author":"Ragonnaud","year":"2019","journal-title":"Canc. Res."},{"key":"10.1016\/j.ejphar.2021.174419_bib60","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.canlet.2006.03.007","article-title":"Structural, functional and therapeutic biology of survivin","volume":"244","author":"Sah","year":"2006","journal-title":"Canc. Lett."},{"key":"10.1016\/j.ejphar.2021.174419_bib61","doi-asserted-by":"crossref","first-page":"107681","DOI":"10.1016\/j.intimp.2021.107681","article-title":"Chemokine CXCL14; a double-edged sword in cancer development","volume":"97","author":"Shabgah","year":"2021","journal-title":"Int. Immunopharm."},{"key":"10.1016\/j.ejphar.2021.174419_bib62","article-title":"CXC chemokine ligand 16: a Swiss army knife chemokine in cancer","volume":"23","author":"Shabgah","year":"2021","journal-title":"Expet Rev. Mol. Med."},{"key":"10.1016\/j.ejphar.2021.174419_bib63","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21176357","article-title":"Arctigenin Attenuates breast cancer progression through decreasing GM-CSF\/TSLP\/STAT3\/\u03b2-Catenin signaling","volume":"21","author":"Shi","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejphar.2021.174419_bib64","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1007\/s00109-013-1021-5","article-title":"The metastasis-promoting roles of tumor-associated immune cells","volume":"91","author":"Smith","year":"2013","journal-title":"J. Mol. Med. (Berl.)"},{"key":"10.1016\/j.ejphar.2021.174419_bib65","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.2174\/1389557516666160614005828","article-title":"Dibenzylbutyrolactone lignans - a review of their structural Diversity, biosynthesis, occurrence, identification and importance","volume":"17","author":"Solyomv\u00e1ry","year":"2017","journal-title":"Mini Rev. Med. Chem."},{"key":"10.1016\/j.ejphar.2021.174419_bib66","doi-asserted-by":"crossref","first-page":"2281","DOI":"10.1016\/j.procbio.2015.09.011","article-title":"A simple and effective enrichment process of the antiproliferative lignan arctigenin based on the endogenous enzymatic hydrolysis of Serratula tinctoria and Arctium lappa fruits","volume":"50","author":"S\u00f3lyomv\u00e1ry","year":"2015","journal-title":"Process Biochem."},{"key":"10.1016\/j.ejphar.2021.174419_bib67","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/j.procbio.2015.01.023","article-title":"Identification and isolation of new neolignan and sesquineolignan species: their acid-catalyzed ring closure and specific accumulation in the fruit wall of Cirsium eriophorum (L.) Scop","volume":"50","author":"S\u00f3lyomv\u00e1ry","year":"2015","journal-title":"Process Biochem."},{"key":"10.1016\/j.ejphar.2021.174419_bib68","doi-asserted-by":"crossref","DOI":"10.1155\/2011\/792639","article-title":"Mitogen-activated protein kinases and reactive oxygen species: how can ROS activate MAPK pathways?","volume":"2011","author":"Son","year":"2011","journal-title":"J Signal Transduct"},{"key":"10.1016\/j.ejphar.2021.174419_bib69","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.phymed.2013.08.003","article-title":"Mechanism of arctigenin-mediated specific cytotoxicity against human lung adenocarcinoma cell lines","volume":"21","author":"Susanti","year":"2013","journal-title":"Phytomedicine"},{"key":"10.1016\/j.ejphar.2021.174419_bib70","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1038\/nrclinonc.2015.61","article-title":"Targeting Notch, Hedgehog, and Wnt pathways in cancer stem cells: clinical update","volume":"12","author":"Takebe","year":"2015","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.ejphar.2021.174419_bib71","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/978-1-59745-157-4_4","article-title":"LC3 and autophagy","volume":"445","author":"Tanida","year":"2008","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.ejphar.2021.174419_bib72","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1023\/B:PHYT.0000045487.02836.32","article-title":"Diversity in lignan biosynthesis","volume":"2","author":"Umezawa","year":"2003","journal-title":"Phytochemistry Rev."},{"key":"10.1016\/j.ejphar.2021.174419_bib73","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1002\/jbt.21533","article-title":"Arctigenin enhances chemosensitivity to cisplatin in human nonsmall lung cancer H460 cells through downregulation of survivin expression","volume":"28","author":"Wang","year":"2014","journal-title":"J. Biochem. Mol. Toxicol."},{"key":"10.1016\/j.ejphar.2021.174419_bib74","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1002\/mnfr.201400558","article-title":"Arctigenin in combination with quercetin synergistically enhances the antiproliferative effect in prostate cancer cells","volume":"59","author":"Wang","year":"2015","journal-title":"Mol. Nutr. Food Res."},{"key":"10.1016\/j.ejphar.2021.174419_bib75","doi-asserted-by":"crossref","first-page":"8628","DOI":"10.1038\/sj.onc.1207232","article-title":"TRAIL and apoptosis induction by TNF-family death receptors","volume":"22","author":"Wang","year":"2003","journal-title":"Oncogene"},{"key":"10.1016\/j.ejphar.2021.174419_bib76","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.bbrc.2019.09.086","article-title":"Arctigenin enhances the sensitivity of cisplatin resistant colorectal cancer cell by activating autophagy","volume":"520","author":"Wang","year":"2019","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ejphar.2021.174419_bib77","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1016\/j.bbrc.2017.09.117","article-title":"Arctigenin represses TGF-\u03b2-induced epithelial mesenchymal transition in human lung cancer cells","volume":"493","author":"Xu","year":"2017","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ejphar.2021.174419_bib78","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1002\/ar.22497","article-title":"Arctigenin anti-tumor activity in bladder cancer T24 cell line through induction of cell-cycle arrest and apoptosis","volume":"295","author":"Yang","year":"2012","journal-title":"Anat. Rec."},{"key":"10.1016\/j.ejphar.2021.174419_bib79","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1158\/1535-7163.MCT-11-0047","article-title":"The role of autophagy in cancer: therapeutic implications","volume":"10","author":"Yang","year":"2011","journal-title":"Mol. Canc. Therapeut."},{"key":"10.1016\/j.ejphar.2021.174419_bib80","doi-asserted-by":"crossref","first-page":"2837","DOI":"10.1002\/jcb.23198","article-title":"Arctigenin enhances chemosensitivity of cancer cells to cisplatin through inhibition of the STAT3 signaling pathway","volume":"112","author":"Yao","year":"2011","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.ejphar.2021.174419_bib81","doi-asserted-by":"crossref","first-page":"2247","DOI":"10.1016\/j.fct.2010.05.056","article-title":"Lignans inhibit cell growth via regulation of Wnt\/beta-catenin signaling","volume":"48","author":"Yoo","year":"2010","journal-title":"Food Chem. Toxicol."},{"key":"10.1016\/j.ejphar.2021.174419_bib82","doi-asserted-by":"crossref","first-page":"571","DOI":"10.4014\/jmb.1901.01061","article-title":"Arctigenin inhibits etoposide resistance in HT-29 colon cancer cells during microenvironmental stress","volume":"29","author":"Yoon","year":"2019","journal-title":"J. Microbiol. Biotechnol."},{"key":"10.1016\/j.ejphar.2021.174419_bib83","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.immuni.2010.03.003","article-title":"The NLRP3 inflammasome protects against loss of epithelial integrity and mortality during experimental colitis","volume":"32","author":"Zaki","year":"2010","journal-title":"Immunity"},{"key":"10.1016\/j.ejphar.2021.174419_bib84","article-title":"Arctigenin induced gallbladder cancer senescence through modulating epidermal growth factor receptor pathway","volume":"39","author":"Zhang","year":"2017","journal-title":"Tumour Biol"},{"key":"10.1016\/j.ejphar.2021.174419_bib85","doi-asserted-by":"crossref","first-page":"117983","DOI":"10.1016\/j.lfs.2020.117983","article-title":"Arctigenin inhibits proliferation of ER-positive breast cancer cells through cell cycle arrest mediated by GSK3-dependent cyclin D1 degradation","volume":"256","author":"Zhu","year":"2020","journal-title":"Life Sci."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299921005720?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299921005720?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T22:54:31Z","timestamp":1757976871000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299921005720"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10]]},"references-count":85,"alternative-id":["S0014299921005720"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2021.174419","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2021,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Arctigenin, an anti-tumor agent; a cutting-edge topic and up-to-the-minute approach in cancer treatment","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2021.174419","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"174419"}}